Abstract

Intra-tumoral heterogeneity is a hallmark of glioblastoma that challenges treatment efficacy. However, the mechanisms that set up tumor heterogeneity and tumor cell migration remain poorly understood. Herein, we present a comprehensive spatiotemporal study that aligns distinctive intra-tumoral histopathological structures, oncostreams, with dynamic properties and a specific, actionable, spatial transcriptomic signature. Oncostreams are dynamic multicellular fascicles of spindle-like and aligned cells with mesenchymal properties, detected using ex vivo explants and in vivo intravital imaging. Their density correlates with tumor aggressiveness in genetically engineered mouse glioma models, and high grade human gliomas. Oncostreams facilitate the intra-tumoral distribution of tumoral and non-tumoral cells, and potentially the collective invasion of the normal brain. These fascicles are defined by a specific molecular signature that regulates their organization and function. Oncostreams structure and function depend on overexpression of COL1A1. Col1a1 is a central gene in the dynamic organization of glioma mesenchymal transformation, and a powerful regulator of glioma malignant behavior. Inhibition of Col1a1 eliminates oncostreams, reprograms the malignant histopathological phenotype, reduces expression of the mesenchymal associated genes, induces changes in the tumor microenvironment and prolongs animal survival. Oncostreams represent a pathological marker of potential value for diagnosis, prognosis, and treatment.

It is essential to improve our understanding of the features that influence aggressiveness and invasion in high grade gliomas (HGG). Here, the authors characterize dynamic anatomical structures in HGG called oncostreams, which are associated with tumor growth and are regulated by COL1A1.

Details

Title
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression
Author
Comba, Andrea 1   VIAFID ORCID Logo  ; Faisal, Syed M. 1   VIAFID ORCID Logo  ; Dunn, Patrick J. 1 ; Argento, Anna E. 2   VIAFID ORCID Logo  ; Hollon, Todd C. 3 ; Al-Holou, Wajd N. 3 ; Varela, Maria Luisa 1   VIAFID ORCID Logo  ; Zamler, Daniel B. 1   VIAFID ORCID Logo  ; Quass, Gunnar L. 4   VIAFID ORCID Logo  ; Apostolides, Pierre F. 5 ; Abel, Clifford 1 ; Brown, Christine E. 6   VIAFID ORCID Logo  ; Kish, Phillip E. 7   VIAFID ORCID Logo  ; Kahana, Alon 8 ; Kleer, Celina G. 9   VIAFID ORCID Logo  ; Motsch, Sebastien 10   VIAFID ORCID Logo  ; Castro, Maria G. 1   VIAFID ORCID Logo  ; Lowenstein, Pedro R. 11   VIAFID ORCID Logo 

 University of Michigan Medical School, Department of Neurosurgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Cell and Developmental Biology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Rogel Cancer Center, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Department of Neurosurgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Cell and Developmental Biology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Department of Neurosurgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Kresge Hearing Research Institute, Department of Otolaryngology-Head & Neck Surgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Kresge Hearing Research Institute, Department of Otolaryngology-Head & Neck Surgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Molecular & Integrative Physiology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 City of Hope, Department of Hematology & Hematopoietic Cell Transplantation, National Medical Center, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357) 
 University of Michigan Medical School, Department of Neurosurgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Ophthalmology & Visual Science, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Ophthalmology & Visual Science, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 University of Michigan Medical School, Rogel Cancer Center, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
10  Arizona State University, School of Mathematical and Statistical Sciences, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636) 
11  University of Michigan Medical School, Department of Neurosurgery, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Department of Cell and Developmental Biology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan Medical School, Rogel Cancer Center, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan, Department of Biomedical Engineering, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2680441550
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.